1
|
Rais G, Boutaagount F, Mokfi R, Maskrout M, Bennour S, Senoussi C, Rais F, Lahlou L. The Safety and Effectiveness of Bevacizumab in Metastatic Colorectal Cancer With Unresectable Metastases: A Real-Life Study From the South of Morocco. Cureus 2024; 16:e56733. [PMID: 38646225 PMCID: PMC11033042 DOI: 10.7759/cureus.56733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/21/2024] [Indexed: 04/23/2024] Open
Abstract
Background Colorectal cancer constitutes a significant public health challenge, despite remarkable strides made in the last two decades, particularly in the medical management of metastatic stages. Notable progress has been achieved through targeted therapies such as anti-epidermal growth factor receptors or anti-angiogenic antibodies, as well as advancements in surgical approaches for hepatic metastases. This study seeks to assess the efficacy and safety of bevacizumab plus chemotherapy in individuals with metastatic colorectal cancer. Methodology This is an observational, cross-sectional, retrospective study of all patients who were followed up for metastatic colorectal cancer with unresectable metastases and were treated with bevacizumab in combination with standard chemotherapy from January 2010 until December 2019 in the medical oncology department of the Centre Hospitalier Universitaire (CHU) Souss-Massa of Agadir. Results Of the total 162 cases, 117 (72%) had metastatic disease, and 45 (28%) progressed to metastatic disease after initial treatment. The median age of the patients was 55 years (range = 23-79 years) with a sex ratio of 1.1 (M/F). The tumor was located in the left colon in 135 (83.3%) patients. The results represented adenocarcinoma in 137 (84.6) cases and mucinous subtype in 23 (14.19) cases. The three most common sites of metastasis were the liver (99, 61.1), peritoneum (67, 41.3), and lung (33, 20.3). In the first line, all patients received bi-chemotherapy plus bevacizumab, i.e., fluorouracil, oxaliplatin, and leucovorin in 34 (20.9%) patients; capecitabine plus oxaliplatin in 88 (54.3%) patients; leucovorin, fluorouracil, and irinotecan in 17 (10.4%) patients; and capecitabine plus irinotecan in 23 (14.1%) patients. Response after first-line treatment was progression in 74 (45.7) cases, stability in 42 (25.9) cases, partial response in 35 (21.6) cases, and complete response in 11 (6.8) cases. Nine (6%) patients were able to benefit from surgical resection of metastatic lesions. Overall, 77 (47%) patients received second-line chemotherapy, i.e., 5-FU with irinotecan in 40 (51.8%) cases or with oxaliplatin in 30 (38.8%) cases. Two patients developed undesirable side effects under bevacizumab (hypertension). The median progression-free survival and median overall survival of the study cohort were 9 months and 14 months, respectively. Nevertheless, patients who underwent primary tumor resection (p = 0.048), those with right‑sided tumors (p = 0.022), those who received a higher number of treatment cycles (p = 0.020), and those who received maintenance treatment (p = 0.001) had a longer median overall survival. Conclusions Chemotherapy combination with bevacizumab is considered as the cornerstone of metastatic colorectal cancer treatment in our region. With the new healthcare and social security systems, easier access to expensive treatments and molecular pathology tests is currently available. It is important to highlight that real-world data can offer valuable insights into the daily clinical practice of medical oncology.
Collapse
Affiliation(s)
- Ghizlane Rais
- Medical Oncology, Centre Hospitalier Universitaire (CHU) Souss Massa, Agadir, MAR
- Medical Oncology, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR
| | - Farah Boutaagount
- Medical Oncology, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr, Centre Hospitalier Universitaire (CHU) Souss Massa, Agadir, MAR
| | - Rania Mokfi
- Medical Oncology, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr, Centre Hospitalier Universitaire (CHU) Souss Massa, Agadir, MAR
| | - Meryem Maskrout
- Medical Oncology, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr, CHU Souss MassaCentre Hospitalier Universitaire (CHU) Souss Massa, Agadir, MAR
| | - Soundous Bennour
- Medical Oncology, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr, Centre Hospitalier Universitaire (CHU) Souss Massa, Agadir, MAR
| | - Chaymae Senoussi
- Medical Oncology, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr, Centre Hospitalier Universitaire (CHU) Souss Massa, Agadir, MAR
| | - Fadoua Rais
- Radiation Therapy, University Hospital Center of Montreal, Montreal, CAN
| | - Laila Lahlou
- Epidemiology and Clinical Research Laboratory, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR
| |
Collapse
|
2
|
Rais G, Maskrout M, Mokfi R, Rais F, Serhane H. Isolated Endobronchial Metastasis of Breast Cancer Successfully Managed With Multimodal Treatment. Cureus 2023; 15:e49891. [PMID: 38174170 PMCID: PMC10762653 DOI: 10.7759/cureus.49891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/03/2023] [Indexed: 01/05/2024] Open
Abstract
Isolated endobronchial metastases of breast cancers, without other visceral metastatic involvement, are exceptional. We report here an observation of isolated endobronchial metastasis discovered 18 months after complete treatment of breast carcinoma. The endobronchial metastasis was revealed by an incoercible cough and hemoptysis. A bronchoscopy revealed a budding tumor process obstructing the right stem bronchus and a biopsy was performed. The anatomopathological and immunohistochemical analysis confirmed the metastatic nature of the endobronchial tumor. The patient received treatment with palbociclib and aromatase inhibitors. Two years after radiotherapy and under hormone treatment, the patient is in complete remission of her breast cancer and endobronchial metastasis. Emerging research suggests that oligometastatic breast cancer carries a superior prognosis. We believe that patients with oligometastatic breast cancer should be treated with curative intent, including ablative therapy to all sites of disease if it can be safely accomplished. This approach may offer an additional chance for prolonged survival.
Collapse
Affiliation(s)
- Ghizlane Rais
- Medical Oncology Department, CHU (Centre Hospitalo-Universitaire) Souss Massa, Agadir, MAR
- Oncology Department, Biomed Laboratory, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, MAR
| | - Meryem Maskrout
- Medical Oncology Department, CHU (Centre Hospitalo-Universitaire) Souss Massa, Agadir, MAR
- Oncology Department, Ibn Zohr University, Medical School of Agadir, Agadir, MAR
| | - Rania Mokfi
- Medical Oncology Department, CHU (Centre Hospitalo-Universitaire) Souss Massa, Agadir, MAR
- Oncology Department, Ibn Zohr University, Medical School of Agadir, Agadir, MAR
| | - Fadoua Rais
- Radiation Therapy Department, University Hospital Center of Montreal, Montreal, CAN
| | - Hind Serhane
- Pulmonology Department, CHU (Centre Hospitalo-Universitaire) Souss Massa, Agadir, MAR
| |
Collapse
|
3
|
Rais F, Boudam K, Ménard C, Beauchemin MC, Oulmoudne N, Juneau D, Leblond A, Barkati M. Role of 18F-choline and 18F-fluorodeoxyglucose positron emission tomography in combination with magnetic resonance imaging in brachytherapy planning for locally advanced cervical cancer: A pilot study. Phys Imaging Radiat Oncol 2023; 27:100467. [PMID: 37497190 PMCID: PMC10366634 DOI: 10.1016/j.phro.2023.100467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Revised: 06/29/2023] [Accepted: 06/29/2023] [Indexed: 07/28/2023] Open
Abstract
Background and purpose This pilot study aims to describe the advantages of combining metabolic and anatomic imaging modalities in brachytherapy (BT) planning for locally advanced cervical cancer (LACC) and to evaluate the supplementary value of Fluoro(F)-Choline positron emission tomography/computed tomography (PET/CT) in comparison to 18F-fluorodeoxyglucose (FDG) in this setting. Materials and methods A prospective cohort of six patients with LACC was included in this study. Each patient underwent BT planning CT scan, magnetic resonance imaging (MRI), and both FDG and F-Choline PET/CT scans on the same day, with BT applicators in place. Patients were treated according to the standard of care. Metabolic target volumes (TV) were generated retrospectively and compared with the anatomic volumes using Dice coefficients and absolute volume comparison. Results The threshold at which the metabolic and anatomic volumes were the most concordant was found to be 35% maximum standardized uptake value (SUV max) for both PET/CT scans. Amongst the six patients in this cohort, three in the FDG cohort and four in the F-Choline cohort were found to have more than ten percent ratio of excess (increase) in their MRI gross tumor volumes (GTV) when incorporating the metabolic information from the PET/CT scans. However, no significant changes were needed in the high risk-clinical target volumes (CTVHR) for both PET tracers. Conclusions FDG and F-Choline PET/CT scans can substantially modify the BT GTV on MRI, without affecting the CTVHR. F-Choline is potentially more informative than FDG in assessing residual TV, particularly in cases with significant post-radiation inflammatory changes.
Collapse
Affiliation(s)
- Fadoua Rais
- Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 St-Denis, Montreal, Québec H2X 0C1, Canada
| | - Karim Boudam
- Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 St-Denis, Montreal, Québec H2X 0C1, Canada
| | - Cynthia Ménard
- Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 St-Denis, Montreal, Québec H2X 0C1, Canada
| | - Marie-Claude Beauchemin
- Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 St-Denis, Montreal, Québec H2X 0C1, Canada
| | - Naoual Oulmoudne
- Department of Radiation Oncology, Centre hospitalier affilié universitaire régional (CHAUR), 1991 boul. du Carmel, Trois-Rivières, Québec G8Z 3R9, Canada
| | - Daniel Juneau
- Department of Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 St-Denis, Montreal, Québec H2X 0C1, Canada
| | - Antoine Leblond
- Department of Nuclear Medicine, Centre hospitalier affilié universitaire régional (CHAUR), 1991 boul. du Carmel, Trois-Rivières, Québec G8Z 3R9, Canada
| | - Maroie Barkati
- Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 St-Denis, Montreal, Québec H2X 0C1, Canada
| |
Collapse
|
4
|
Rais G, Bourhafour M, Nafidi FZ, Rais F. A Huge Sister Mary Joseph’s Nodule From Signet Ring Cell Gastric Carcinoma Showing Good Response to FOLFOX-Based Chemotherapy Regimen. J Med Cases 2022; 13:115-118. [PMID: 35356399 PMCID: PMC8929212 DOI: 10.14740/jmc3895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 02/04/2022] [Indexed: 11/29/2022] Open
Abstract
Metastatic involvement of the umbilicus as a result of a visceral carcinoma is a rare entity known as Sister Mary Joseph’s nodule (SMJN). The most common primary sites are the gastrointestinal and gynecological tract. The occurrence of SMJN is commonly associated with advanced peritoneal disease and poor prognosis. The average survival time at the appearance of an umbilical metastasis is estimated at 10 months, and only 13% of patient will be alive at 2 years. Treatment usually involves systemic chemotherapy and palliative care, but the possibility of surgical resection should be considered especially if good response to systemic treatment is achieved in selected patients to maintain or to improve the quality of life. We describe here an unusual case of a 60-year-old man referred with enlarging umbilical lesion, identified as SMJN, that was metastasized from advanced signet ring cell carcinoma of the stomach with generalized peritoneal carcinomatosis. The nodule had rapid progression, and in a few days had reached 15 cm. Chemotherapy was started immediately and patient achieved good clinical and radiological response. A resection of the umbilical nodule was discussed but the patient unfortunately died following a massive pulmonary embolism. This case is unique in view of the unusual size of the SMJN in our patient and the good response to chemotherapy. We present this case to increase physician’s awareness for careful evaluation of the umbilical area and encourage them to look for a primary digestive tumor if an umbilical nodule is observed. Therapeutic response to primary chemotherapy may encourage a multimodal approach allowing resectability of the metastatic umbilical nodule.
Collapse
Affiliation(s)
- Ghizlane Rais
- Medical Oncology Department, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr , Agadir, CHU Souss Massa, Morocco
- Corresponding Author: Ghizlane Rais, Medical Oncology Department, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr , Agadir, CHU Souss Massa, Morocco.
| | - Mouna Bourhafour
- Medical Oncology Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II, CHU Ibn Rochd, Casablanca, Morocco
| | - Fatima Zahra Nafidi
- Medical Oncology Department, Faculty of Medicine and Pharmacy of Agadir, University Ibn Zohr , Agadir, CHU Souss Massa, Morocco
| | - Fadoua Rais
- Radiotherapy Department, University Hospital Center of Montreal, Montreal, QC, Canada
| |
Collapse
|
5
|
Rais F. 25: Extreme Weekly Loco-Regional Hypofractionated Radiation in Elderly Women with Non-Metastatic Breast Cancer. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)08903-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
6
|
Rais F, Tsui J, Faye M, Daianska A, Lambert C, David M, Panet-Raymond V, Azoulay M, Saidi A, Hijal T. PO-1115 Extreme weekly locoregional hypofractionated radiation in elderly with non-metastatic breast cancer. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07566-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
7
|
Rais G, Maidi M, Rais F. Successful Management of Intrathoracic Phrenic Malignant Peripheral Nerve Sheath Tumor by Multimodal Treatment. J Med Cases 2020; 11:120-124. [PMID: 34434380 PMCID: PMC8383559 DOI: 10.14740/jmc3464] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2020] [Accepted: 04/13/2020] [Indexed: 11/25/2022] Open
Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are rare and can be associated with type 1 neurofibromatosis. They are rarely located at the mediastinum, most often at the posterior mediastinal compartment or the paravertebral gutters. MPNSTs of the anterior mediastinum arising from the phrenic nerve are exceptional. Their prognosis is poor due to the high potential of local tumor recurrence and metastasis. Complete surgical resection remains the only radical treatment. However, the outcomes after this treatment alone cannot be considered satisfactory. Preoperative chemotherapy could be an interesting therapeutic option for unresectable tumors. We report here the case of a 77-year-old woman with an MPNST located at the anterior mediastinum arising from the phrenic nerve. This tumor was successfully managed with multimodal therapy combining preoperative chemotherapy, complete surgery and adjuvant radiation.
Collapse
Affiliation(s)
- Ghizlane Rais
- Department of Medical Oncology, Regional Center of Oncology, Agadir, Morocco
| | - Mehdi Maidi
- Department of Thoracic Surgery, CHU AGADIR, Agadir, Morocco
| | - Fadoua Rais
- Radiotherapy Department, McGill University Cedars Cancer, Montreal, Canada
| |
Collapse
|
8
|
de Oliveira AF, Rais F, Dettori I, Azzena M, Nieddu G. UV Light Acclimation Capacity of Leaf Photosynthetic and Photochemical Behaviour in Near-isohydric and Anisohydric Grapevines in Hot and Dry Environments. S AFR J ENOL VITIC 2019. [DOI: 10.21548/40-2-3235] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
9
|
Rais F, Benhmidou N, Rais G, Maghous A, Loughlimi H, Kouhen F, Aarab J, Bellahammou K, Khmou M, Laadam K, Zouaidia F, Elmejjaoui S, Kebdani T, Elkacemi H, Benjaafar N. NEUROBLASTOMA IN AN ADULT: A CASE REPORT OF A RARE ENTITY WITH A SUMMARY REVIEW. IJSM 2017. [DOI: 10.5455/ijsm.neuroblastoma] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
10
|
Lakhdissi A, Elghissassi I, Bellahammou K, Balde S, Akla S, Azakhman M, Zouaidia F, Mahassini N, Rais F, Benjaafer N, Mrabti H, Errihani H. A RECURRENCE BIPHASIC PULMONARY BLASTOMA AFTER ADJUVANT CHEMOTHERAPY : A CASE REPORT OF RARE LUNG MALIGNANCY. IJSM 2017. [DOI: 10.5455/ijsm.pulmonary-blastoma-recurrence] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
11
|
Bellahammou K, Lakhdissi A, Akkar O, Salmi N, Zakkouri F, Dahraoui S, Rais F, Mrabti H, Errihani H. AGGRESSIVE MULTIPLE MYELOMA IN A YOUNG ADULT: A CASE REPORT. IJSM 2017. [DOI: 10.5455/ijsm.multiplemyeloma] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
12
|
Benhmidou N, Rais F, Aissa A, Akkar O, Bellahammou K, Loughlimi H, Maghous A, Kouhen F, Kebdani T, Elkacemi H, Elmajjaoui S, Benjaafar N. BRAIN METASTASIS FROM UTERINE MALIGNANCIES: TREATMENT MODALITIES AND PROGNOSTIC FACTORS. IJSM 2017. [DOI: 10.5455/ijsm.brain-metastases-uterine] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
13
|
Benhmidou N, Rais F, Kouhen F, Maghous A, Loughlimi H, Bellahammou K, Elkacemi H, Kebdani T, Elmajjaoui S, Benjaafar N. PHYLLODES TUMOR OF THE BREAST : A CLINICOPATHOLOGICAL ANALYSIS FROM A SINGLE INSTITUTION. IJSM 2017. [DOI: 10.5455/ijsm.phyllodes-tumor-breast] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
14
|
Bellahammou K, Lakhdissi A, Akkar O, Kouhen F, Rais F, Dahraoui S, Mrabti H, Errihani H. SMALL-CELL NEUROENDOCRINE CARCINOMA OF NASOPHARYNX: A CASE REPORT. IJSM 2017. [DOI: 10.5455/ijsm.nasopharynx-carcinoma] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
15
|
Bellahammou K, Lakhdissi A, Akkar O, Rais F, Naoual B, Elghissassi I, M'rabti H, Errihani H. Metastatic giant basal cell carcinoma: a case report. Pan Afr Med J 2016; 24:157. [PMID: 27795755 PMCID: PMC5072823 DOI: 10.11604/pamj.2016.24.157.9233] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2016] [Accepted: 06/07/2016] [Indexed: 11/29/2022] Open
Abstract
Basal cell carcinoma is the most common skin cancer, characterised by a slow growing behavior, metastasis are extremely rare, and it occurs in less than 0, 1% of all cases. Giant basal cell carcinoma is a rare form of basal cell carcinoma, more aggressive and defined as a tumor measuring more than 5 cm at its largest diameter. Only 1% of all basal cell carcinoma develops to a giant basal cell carcinoma, resulting of patient's negligence. Giant basal cell carcinoma is associated with higher potential of metastasis and even death, compared to ordinary basal cell carcinoma. We report a case of giant basal cell carcinoma metastaticin lung occurring in a 79 years old male patient, with a fatal evolution after one course of systemic chemotherapy. Giant basal cell carcinoma is a very rare entity, early detection of these tumors could prevent metastasis occurrence and improve the prognosis of this malignancy.
Collapse
Affiliation(s)
- Khadija Bellahammou
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
| | - Asmaa Lakhdissi
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
| | - Othman Akkar
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
| | - Fadoua Rais
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Benhmidou Naoual
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Ibrahim Elghissassi
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
| | - Hind M'rabti
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
| | - Hassan Errihani
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
| |
Collapse
|
16
|
Kouhen F, Benhmidou N, Afif M, Rais F, Khamou M, Khanoussi B, El Menaoui O, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N. Prognosis of Medullary Carcinoma of the Breast: 10 years' Experience in a Single Institution. Breast J 2016; 23:112-114. [PMID: 27671230 DOI: 10.1111/tbj.12699] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Fadila Kouhen
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Nawal Benhmidou
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Mohammed Afif
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Fadoua Rais
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Mouna Khamou
- Department of Pathology, National Institute of Oncology, Rabat, Morocco
| | - Basma Khanoussi
- Department of Pathology, National Institute of Oncology, Rabat, Morocco
| | - Ouadie El Menaoui
- Department of Radiology, National Institute of Oncology, Rabat, Morocco
| | - Hanan Elkacemi
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Sanaa Elmajjaoui
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Tayeb Kebdani
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | | |
Collapse
|
17
|
Rais F, Benhmidou N, Rais G, Loughlimi H, Kouhen F, Maghous A, Aarab J, Bellahammou K, Moukinebillah M, Khattab M, Chala S, Elmejjaoui S, Kebdani T, Elkacemi H, Benjaafar N. Wilms tumor in childhood: Single centre retrospective study from the National Institute of Oncology of Rabat and literature review. Pediatric Hematology Oncology Journal 2016. [DOI: 10.1016/j.phoj.2016.07.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
|
18
|
Maghous A, Rais F, Ahid S, Benhmidou N, Bellahamou K, Loughlimi H, Marnouche E, Elmajjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Factors influencing diagnosis delay of advanced breast cancer in Moroccan women. BMC Cancer 2016. [PMID: 27268201 DOI: 10.1186/s12885-016-2394-y.pmid:27268201freepmc] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Abstract
BACKGROUND Delay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated with advanced stage and low survival. We conducted this study to learn more about the extent and reasons behind diagnosis delay of advanced breast cancer in Moroccan women. METHODS A group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information and clinical data were collected on a form during an interview with each patient and from medical records. RESULTS In all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000). Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001). CONCLUSIONS Diagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer information in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.
Collapse
Affiliation(s)
- A Maghous
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
| | - F Rais
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Ahid
- Laboratory of epidemiology and clinical research, School of medicine and pharmacy of Rabat, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benhmidou
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - K Bellahamou
- Department of Medical Oncology, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Loughlimi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - E Marnouche
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Elmajjaoui
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Elkacemi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - T Kebdani
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benjaafar
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| |
Collapse
|
19
|
Maghous A, Rais F, Ahid S, Benhmidou N, Bellahamou K, Loughlimi H, Marnouche E, Elmajjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Factors influencing diagnosis delay of advanced breast cancer in Moroccan women. BMC Cancer 2016; 16:356. [PMID: 27268201 PMCID: PMC4897875 DOI: 10.1186/s12885-016-2394-y] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Accepted: 06/02/2016] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Delay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated with advanced stage and low survival. We conducted this study to learn more about the extent and reasons behind diagnosis delay of advanced breast cancer in Moroccan women. METHODS A group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information and clinical data were collected on a form during an interview with each patient and from medical records. RESULTS In all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000). Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001). CONCLUSIONS Diagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer information in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.
Collapse
Affiliation(s)
- A Maghous
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
| | - F Rais
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Ahid
- Laboratory of epidemiology and clinical research, School of medicine and pharmacy of Rabat, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benhmidou
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - K Bellahamou
- Department of Medical Oncology, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Loughlimi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - E Marnouche
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Elmajjaoui
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Elkacemi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - T Kebdani
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benjaafar
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| |
Collapse
|
20
|
Taiaa O, Rais F, Latib R, Chami I, Benjaafar N, Boujida N. Imagerie des cylindromes : à propos de 9 cas. J Neuroradiol 2016. [DOI: 10.1016/j.neurad.2016.01.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
21
|
Benhmidou N, Rais F, Bellahammou K, Maghous A, Loughlimi H, kamouni M, Kouhen F, Elmajjaoui S, Kebdani T, Elkacemi H, Benjaafar N. MANAGEMENT OF EXTRAMEDULLARY PLASMOCYTOMA OF HEAD AND NECK. IJSM 2016. [DOI: 10.5455/ijsm.extramedullary-plasmocytoma] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
22
|
Bellahammou K, Lakhdissi A, Othman A, Narimane S, Ghissassi I, Rais F, Benhmidou N, Mrabti H, Errihani H. INVASIVE PULMONARY ASPERGILLOSIS FOLLOWING BEVACIZUMAB TREATMENT FOR NON-SMALL CELL LUNG CANCER. IJSM 2016. [DOI: 10.5455/ijsm.invasive-pulmonary-aspergillosis] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
23
|
Kouhen F, Afif M, Benhmidou N, Rais F, El Kabous M, Khmou M, Cherradi N, Majjaoui S, Elkacemi H, Kebdani T, Benjaafar N. [Head and neck synovial sarcoma: a rare location: report of two cases]. Pan Afr Med J 2015; 20:232. [PMID: 26140075 PMCID: PMC4482523 DOI: 10.11604/pamj.2015.20.232.6225] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2015] [Accepted: 02/06/2015] [Indexed: 11/23/2022] Open
Abstract
La localisation ORL du synovialosarcome est rare représentant moins de 5% des tumeurs de la région. Sa prise en charge est multidisciplinaire reposant sur une chirurgie large et complète suivie d'une radiothérapie externe. Nous rapportons deux cas de synovialosarcome de l'oropharynx et du sinus maxillaire chez deux adultes jeunes traités par une chirurgie et une radiothérapie externe avec une bonne réponse locorégionale.
Collapse
Affiliation(s)
- Fadila Kouhen
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Mohammed Afif
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Naoual Benhmidou
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Fadoua Rais
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Mustapha El Kabous
- Service d'Oncologie Médicale, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Mouna Khmou
- Service d'Anatomopathologie, Hôpital des Spécialités, Université Mohammed V, Rabat, Maroc
| | - Nadia Cherradi
- Service d'Anatomopathologie, Hôpital des Spécialités, Université Mohammed V, Rabat, Maroc
| | - Sanaa Majjaoui
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Hanan Elkacemi
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Tayeb Kebdani
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| | - Noureddine Benjaafar
- Service de Radiothérapie, Institut National d'Oncologie, Université Mohammed V, Rabat, Maroc
| |
Collapse
|
24
|
Rais F, Benhmidou N, Rais G, Kouhen F, Bellahamou K, Loughlimi H, Maghous A, Elmejjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Solitary intraosseous schwannoma of the base and vault of the skull: a summary review of such unusual location. Clin Sarcoma Res 2015; 5:6. [PMID: 25667745 PMCID: PMC4321328 DOI: 10.1186/s13569-015-0023-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2014] [Accepted: 01/15/2015] [Indexed: 11/10/2022] Open
Abstract
Intra-osseous schwannoma is a rare mesenchymal tumor. Although, the head and neck region is one of the most common sites for schwannomas, its location at the skull bone is uncommon and accounted for less than 0.2% in the largest series of bone tumors ever reported. Furthermore, it is most often a benign tumor, malignant transformation is exceedingly rare. Clinical presentation is non-specific, most often symptoms are associated with compression and invasion of adjacent organs. Neuro-imaging features are non-specific and the diagnosis is based on histological examination with immunohistochemical study. Surgery remains the aim of treatment. However, radiation therapy could be an interesting therapeutic option in unresectable tumors. This systemic review offers new clinicopathological data useful for better defining the diagnosis and clinicopathological behavior of schwannoma. The purpose of this work is to raise awareness among clinicians adding this clinical entity as a differential diagnosis when a mass of skull bone is identified.
Collapse
Affiliation(s)
- Fadoua Rais
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Naoual Benhmidou
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Ghizlane Rais
- />Department of Oncology, National Institute of Oncology, Rabat, Morocco
| | - Fadila Kouhen
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Khadija Bellahamou
- />Department of Oncology, National Institute of Oncology, Rabat, Morocco
| | - Hasna Loughlimi
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Abdelhak Maghous
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Sanae Elmejjaoui
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Hanan Elkacemi
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - Tayeb Kebdani
- />Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | | |
Collapse
|
25
|
Raissouni S, Raissouni F, Rais G, Aitelhaj M, Lkhoyaali S, Latib R, Mohtaram A, Rais F, Mrabti H, Kabbaj N, Amrani N, Errihani H. Radiation induced esophageal adenocarcinoma in a woman previously treated for breast cancer and renal cell carcinoma. BMC Res Notes 2012; 5:426. [PMID: 22873795 PMCID: PMC3480838 DOI: 10.1186/1756-0500-5-426] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2012] [Accepted: 08/02/2012] [Indexed: 11/28/2022] Open
Abstract
Background Secondary radiation-induced cancers are rare but well-documented as long-term side effects of radiation in large populations of breast cancer survivors. Multiple neoplasms are rare. We report a case of esophageal adenocarcinoma in a patient treated previously for breast cancer and clear cell carcinoma of the kidney. Case presentation A 56 year-old non smoking woman, with no alcohol intake and no familial history of cancer; followed in the National Institute of Oncology of Rabat Morocco since 1999 for breast carcinoma, presented on consultation on January 2011 with dysphagia. Breast cancer was treated with modified radical mastectomy, 6 courses of chemotherapy based on CMF regimen and radiotherapy to breast, inner mammary chain and to pelvis as castration. Less than a year later, a renal right mass was discovered incidentally. Enlarged nephrectomy realized and showed renal cell carcinoma. A local and metastatic breast cancer recurrence occurred in 2007. Patient had 2 lines of chemotherapy and 2 lines of hormonotherapy with Letrozole and Tamoxifen assuring a stable disease. On January 2011, the patient presented dysphagia. Oesogastric endoscopy showed middle esophagus stenosing mass. Biopsy revealed adenocarcinoma. No evidence of metastasis was noticed on computed tomography and breast disease was controlled. Palliative brachytherapy to esophagus was delivered. Patient presented dysphagia due to progressive disease 4 months later. Jejunostomy was proposed but the patient refused any treatment. She died on July 2011. Conclusion We present here a multiple neoplasm in a patient with no known family history of cancers. Esophageal carcinoma is most likely induced by radiation. However the presence of a third malignancy suggests the presence of genetic disorders.
Collapse
Affiliation(s)
- Soundouss Raissouni
- Medical Oncology Department, National Institute of Oncology, Rabat, Morocco.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Yusof M, Rais F, Akhmal M, Kasim F. Molecular Epidemiology of Human Enterovirus 71 Strains Isolated in Peninsular Malaysia from Year 2000–2007 Based on the Complete VP4 Gene. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|